Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Swann

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
International Journal of Geriatric Psychiatry|July 27, 2007
Bouffee Delirante in a 69-year-old male precipitated by stress of caringAnurita Singh, Alan Swann
The Practitioner|November 1, 2002
Casebook: assessing confusionAlan Swann, Clive Ballard
Current Psychiatry Reports|August 27, 2015
Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other ApproachesRayan K Al Jurdi, Alan Swann, Sanjay J Mathew
The International Journal of Neuroscience|September 16, 2005
Sex differences in tail-flick latency of non-stressed and stressed ratsSady Ribeiro, Pamela Yang, Cruz Reyes-Vazquez, et al.
Age and Ageing|July 22, 2008
Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative studyAmy Wood-Mitchell, Ian Andrew James, Anna Waterworth, et al.
Irish Journal of Psychological Medicine|September 12, 2018
Tardive dysphoria: antidepressant-induced chronic depressionRif S El-Mallakh, R Jeannie Roberts, Alan Swann, et al.
Current Medical Research and Opinion|February 11, 2005
Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settingsDeirdre M Mladsi, Amy L Grogg, William D Irish, et al.
CNS Drugs|March 15, 2006
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trialsRichard H Weisler, Robert Hirschfeld, Andrew J Cutler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 19, 2023
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 22, 2023
Correction: Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
International Journal of Geriatric Psychiatry|July 27, 2007
Bouffee Delirante in a 69-year-old male precipitated by stress of caringAnurita Singh, Alan Swann
The Practitioner|November 1, 2002
Casebook: assessing confusionAlan Swann, Clive Ballard
Current Psychiatry Reports|August 27, 2015
Psychopharmacological Agents and Suicide Risk Reduction: Ketamine and Other ApproachesRayan K Al Jurdi, Alan Swann, Sanjay J Mathew
The International Journal of Neuroscience|September 16, 2005
Sex differences in tail-flick latency of non-stressed and stressed ratsSady Ribeiro, Pamela Yang, Cruz Reyes-Vazquez, et al.
Age and Ageing|July 22, 2008
Factors influencing the prescribing of medications by old age psychiatrists for behavioural and psychological symptoms of dementia: a qualitative studyAmy Wood-Mitchell, Ian Andrew James, Anna Waterworth, et al.
Irish Journal of Psychological Medicine|September 12, 2018
Tardive dysphoria: antidepressant-induced chronic depressionRif S El-Mallakh, R Jeannie Roberts, Alan Swann, et al.
Current Medical Research and Opinion|February 11, 2005
Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settingsDeirdre M Mladsi, Amy L Grogg, William D Irish, et al.
CNS Drugs|March 15, 2006
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trialsRichard H Weisler, Robert Hirschfeld, Andrew J Cutler, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 19, 2023
Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 22, 2023
Correction: Neural complexity EEG biomarkers of rapid and post-rapid ketamine effects in late-life treatment-resistant depression: a randomized control trialNicholas Murphy, Amanda J F Tamman, Marijn Lijffijt, et al.
Pageof 2